GGrantIndex
← Leaderboards

Ronald Wayne Davis

Stanford University

$104,341,139
Attributed
$112,228,193
Total exposure
36
Grants
21
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $21.4M · FY200523
$25M$18.8M$12.5M$6.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23

Funding mix

By agency

NIH$233,095,937 · 37

By mechanism

P01$161,817,757 · 7
R01$29,282,615 · 9
U54$15,225,502 · 2
U01$13,490,930 · 2
R21$4,915,331 · 10
R33$4,362,528 · 2

Top collaborators

Most similar at Stanford University

Same institution · by research overlap

Others in their field

Top investigators on “Genome

Research focus

GenomeTechnologyBaseDesignGenomicsYeastsCostSamplingGenesMolecularGeneticComplexProteinsNucleic Acid SequenceCellsGenotypeSaccharomyces CerevisiaeOligonucleotidesAllelesVariantDetectionCommunitiesResponseGene Expression

Grant awards (130)

A nanophotonic approach to building DNA using enzymatic synthesis$350,297
R01 · FY2023 · GM · contact PI
Molecular and single-cell immunology of myalgic encephalomyelitis/chronic fatigue syndrome$695,556
R01 · FY2022 · AI · contact PI
A nanophotonic approach to building DNA using enzymatic synthesis$435,297
R01 · FY2022 · GM · contact PI
Molecular and single-cell immunology of myalgic encephalomyelitis/chronic fatigue syndrome$737,829
R01 · FY2021 · AI · contact PI
A nanophotonic approach to building DNA using enzymatic synthesis$435,297
R01 · FY2021 · GM · contact PI
Molecular and single-cell immunology of myalgic encephalomyelitis/chronic fatigue syndrome$750,389
R01 · FY2020 · AI · contact PI
A nanophotonic approach to building DNA using enzymatic synthesis$530,297
R01 · FY2020 · GM · contact PI
Molecular and single-cell immunology of myalgic encephalomyelitis/chronic fatigue syndrome$762,949
R01 · FY2019 · AI · contact PI
Extended DNA synthesis using a library-based CRISPR/Cas9-engineered enzyme$196,250
R21 · FY2019 · HG · contact PI
Genomic and synthetic biology tools for expressing natural product gene clusters$2,131,527
U01 · FY2018 · GM · contact PI
Molecular and single-cell immunology of myalgic encephalomyelitis/chronic fatigue syndrome$775,509
R01 · FY2018 · AI · contact PI
Nanoneedle microrobots for single cancer cell manipulation and genome editing$314,000
R21 · FY2018 · CA · contact PI
Ultra high-throughput DNA synthesis via nano-optical conveyer belts$303,185
R21 · FY2018 · HG · contact PI
Extended DNA synthesis using a library-based CRISPR/Cas9-engineered enzyme$235,500
R21 · FY2018 · HG · contact PI
Genomic and synthetic biology tools for expressing natural product gene clusters$2,145,981
U01 · FY2017 · GM · contact PI
Mechanisms of Aging in C. elegans$321,850
R01 · FY2017 · AG · contact PI
Nanoneedle microrobots for single cancer cell manipulation and genome editing$314,000
R21 · FY2017 · CA · contact PI
Ultra high-throughput DNA synthesis via nano-optical conveyer belts$301,923
R21 · FY2017 · HG · contact PI
Revolutionizing Biomedical and Clinical Research through Innovative Technology$5,000,000
P01 · FY2016 · HG · contact PI
Genomic and synthetic biology tools for expressing natural product gene clusters$2,206,187
U01 · FY2016 · GM · contact PI
Genomic and synthetic biology tools for expressing natural product gene clusters$15,700
U01 · FY2016 · GM · contact PI
Revolutionizing Biomedical and Clinical Research through Innovative Technology$4,875,000
P01 · FY2015 · HG · contact PI
Genomic and synthetic biology tools for expressing natural product gene clusters$2,210,549
U01 · FY2015 · GM · contact PI
Technology Innovation$1,811,768
P01 · FY2015 · HG · contact PI
Revolutionizing Biomedical and Clinical Research through Innovative Technology$4,900,000
P01 · FY2014 · HG · contact PI
Genomic and synthetic biology tools for expressing natural product gene clusters$2,207,718
U01 · FY2014 · GM · contact PI
Technology Innovation$1,859,417
P01 · FY2014 · HG · contact PI
Quantitative Trait Dissection by Reciprocal Hemizygosity$508,887
R01 · FY2014 · GM · contact PI
Genomics Core$227,848
U19 · FY2014 · AI · contact PI
Revolutionizing Biomedical and Clinical Research through Innovative Technology$7,000,000
P01 · FY2013 · HG · contact PI
Technology Innovation$2,511,957
P01 · FY2013 · HG · contact PI
Quantitative Trait Dissection by Reciprocal Hemizygosity$502,135
R01 · FY2013 · GM · contact PI
Genomics Core$223,113
U19 · FY2013 · AI · contact PI
Revolutionizing Biomedical Research and Medicine through Innovative & Cost-Effect$8,299,749
P01 · FY2012 · HG · contact PI
Technology to Identify and Assay Chemical Genomic Probes$1,117,030
R01 · FY2012 · HG · contact PI
Quantitative Trait Dissection by Reciprocal Hemizygosity$531,504
R01 · FY2012 · GM · contact PI
Genomics Core$222,867
U19 · FY2012 · AI · contact PI
Noninvasive prenatal diagnosis using targeted DNA capture and sequencing.$197,500
R21 · FY2012 · HD · contact PI
Revolutionizing Biomedical Research and Medicine through Innovative & Cost-Effect$8,063,531
P01 · FY2011 · HG · contact PI
Technology to Identify and Assay Chemical Genomic Probes$1,117,031
R01 · FY2011 · HG · contact PI
Discovery of Biomakers in Human Mitochondrial Disorders$566,893
R01 · FY2011 · EY · contact PI
Quantitative Trait Dissection by Reciprocal Hemizygosity$556,618
R01 · FY2011 · GM · contact PI
Genomics Core$406,291
U19 · FY2011 · AI · contact PI
Identification of Small-Molecule Inhibitors of Protein-Protein Interactions$240,000
R21 · FY2011 · HG · contact PI
Isolation Selection and Polony Amplification of Single Cells in a Gel Matrix$237,600
R21 · FY2011 · HG · contact PI
Noninvasive prenatal diagnosis using targeted DNA capture and sequencing.$237,000
R21 · FY2011 · HD · contact PI
MISINCORPORATION OF AMINO ACID ANALOGS IN SELECTED HUMAN AND MURINE PROTEINS$57,367
P41 · FY2011 · RR · contact PI
Revolutionizing Biomedical Research and Medicine through Innovative & Cost-Effect$8,150,705
P01 · FY2010 · HG · contact PI
Core D: Genomics Core$1,379,920
U54 · FY2010 · GM · contact PI
Technology to Identify and Assay Chemical Genomic Probes$1,128,314
R01 · FY2010 · HG · contact PI
A Strategy for High Quality Clinical Resequencing of the Human Genome$796,150
RC2 · FY2010 · HG · contact PI
Quantitative Trait Dissection by Reciprocal Hemizygosity$539,920
R01 · FY2010 · GM · contact PI
Technology to Identify and Assay Chemical Genomic Probes$361,760
R01 · FY2010 · HG · contact PI
Isolation Selection and Polony Amplification of Single Cells in a Gel Matrix$200,000
R21 · FY2010 · HG · contact PI
Identification of Small-Molecule Inhibitors of Protein-Protein Interactions$200,000
R21 · FY2010 · HG · contact PI
Revolutionizing Biomedical Research and Medicine through Innovative & Cost-Effect$7,999,991
P01 · FY2009 · HG · contact PI
Core D: Genomics Core$2,161,793
U54 · FY2009 · GM · contact PI
A Strategy for High Quality Clinical Resequencing of the Human Genome$1,978,579
RC2 · FY2009 · HG · contact PI
Technology to Identify and Assay Chemical Genomic Probes$1,154,710
R01 · FY2009 · HG · contact PI
Discovery of Biomarkers in Human Mitochondrial Diseases$702,354
R01 · FY2009 · EY · contact PI
Quantitative Trait Dissection by Reciprocal Hemizygosity$529,600
R01 · FY2009 · GM · contact PI
Discovery of Biomarkers in Human Mitochondrial Diseases$302,821
R01 · FY2009 · EY · contact PI
TECHNOLOGY DEVELOPMENT$7,896,800
P01 · FY2008 · HG · contact PI
Functional Genomics and Technology$7,896,800
P01 · FY2008 · HG · contact PI
Core D: Genomics Core$2,161,258
U54 · FY2008 · GM · contact PI
Discovery of Biomarkers in Human Mitochondrial Diseases$688,052
R01 · FY2008 · EY · contact PI
Quantitative Trait Dissection by Reciprocal Hemizygosity$514,282
R01 · FY2008 · GM · contact PI
Development of Selectors for Cancer Mutation Analysis$197,500
R21 · FY2008 · CA · contact PI
Functional Genomics and Technology$7,891,904
P01 · FY2007 · HG · contact PI
TECHNOLOGY DEVELOPMENT$7,891,904
P01 · FY2007 · HG · contact PI
Core D: Genomics Core$2,384,605
U54 · FY2007 · GM · contact PI
Identifying chemical probes against all essential genes$948,179
R01 · FY2007 · HG · contact PI
Discovery of Biomarkers in Human Mitochondrial Diseases$667,326
R01 · FY2007 · EY · contact PI
Pyrosequencing Array for Genome Sequencing$567,013
R01 · FY2007 · HG · contact PI
Quantitative Trait Dissection by Reciprocal Hemizygosity$528,829
R01 · FY2007 · GM · contact PI
Development of Selectors for Cancer Mutation Analysis$236,750
R21 · FY2007 · CA · contact PI
Pyrosequencing Array for Genome Sequencing$235,789
R01 · FY2007 · HG · contact PI
TECHNOLOGY DEVELOPMENT$8,160,000
P01 · FY2006 · HG · contact PI
Functional Genomics and Technology$7,968,239
P01 · FY2006 · HG · contact PI
Core D: Genomics Core$2,199,317
U54 · FY2006 · GM · contact PI
Identifying chemical probes against all essential genes$976,497
R01 · FY2006 · HG · contact PI
Discovery of Biomarkers in Human Mitochondrial Diseases$688,662
R01 · FY2006 · EY · contact PI
Quantitative Trait Dissection by Reciprocal Hemizygosity$563,724
R01 · FY2006 · GM · contact PI
TECHNOLOGY DEVELOPMENT$8,000,000
P01 · FY2005 · HG
Functional Genomics and Technology$8,000,000
P01 · FY2005 · HG
Identifying chemical probes against all essential genes$1,300,002
R01 · FY2005 · HG
Quantitative Trait Dissection by Reciprocal Hemizygosity$593,062
R01 · FY2005 · GM
Charge-based Pathogen DNA Detection$316,909
R21 · FY2005 · AI
Genome-wide Characterization of Alternative Splicing$200,000
R21 · FY2005 · RR
Single Molecule Nucleic Acid Detection with Nanopipettes$195,313
R21 · FY2005 · HG
CHAR OF SECRETIVE &MEMBRANE PROTEINS IN PSEUDOMONAS AERUGINOSA$19,440
P41 · FY2005 · RR
Functional Genomics and Technology$7,790,738
P01 · FY2004 · HG
Identifying chemical probes against all essential genes$1,000,000
R01 · FY2004 · HG
Quantitative Trait Dissection by Reciprocal Hemizygosity$616,152
R01 · FY2004 · GM
Charge-based Pathogen DNA Detection$316,401
R21 · FY2004 · AI
Genome-wide Characterization of Alternative Splicing$240,000
R21 · FY2004 · RR
Single Molecule Nucleic Acid Detection with Nanopipettes$235,500
R21 · FY2004 · HG
CHAR OF SECRETIVE &MEMBRANE PROTEINS IN P. AERUGINOSA$64,103
P41 · FY2004 · RR
FUNCITONAL GENOMICS AND TECHNOLOGY$5,516
P51 · FY2004 · RR
Functional Genomics and Technology$7,563,712
P01 · FY2003 · HG
Target Identification via Haplo Insufficiency Profiling$1,369,588
R33 · FY2003 · EB
Quantitative Trait Dissection by Reciprocal Hemizygosity$544,281
R01 · FY2003 · GM
Functional Genomics and Technology$7,343,307
P01 · FY2002 · HG
Target Identification via Haplo Insufficiency Profiling$1,511,752
R33 · FY2002 · CA
AN AIDS-RELATED CRYPTOCOCCUS NEOFORMANS GENOME CENTER$1,204,600
U01 · FY2002 · AI
LARGE SCALE HUMAN DNA SEQUENCING WITH POLYMORPHISM DISC$1,045,910
U54 · FY2002 · HG
TECHNOLOGY DEVELOPMENT$0
P01 · FY2002 · HG
CORE--GENOMICS$0
U54 · FY2002 · GM
CORE--GENOMICS$0
U54 · FY2002 · GM
FUNCTIONAL GENOMICS$0
P01 · FY2002 · HG
INFORMATICS$0
P01 · FY2002 · HG
INSTRUMENTATION$0
P01 · FY2002 · HG
Functional Genomics and Technology$7,279,315
P01 · FY2001 · HG
LARGE SCALE HUMAN DNA SEQUENCING WITH POLYMORPHISM DISC$2,875,486
U54 · FY2001 · HG
Target Identification via Haplo Insufficiency Profiling$1,481,188
R33 · FY2001 · CA
AN AIDS-RELATED CRYPTOCOCCUS NEOFORMANS GENOME CENTER$753,798
U01 · FY2001 · AI
CELL REGULATION--BIOCHEMICALLY ISOLATED DNA SEGMENTS$398,152
R01 · FY2001 · HG
CELL REGULATION--BIOCHEMICALLY ISOLATED DNA SEGMENTS$132,718
R01 · FY2001 · HG
CORE--GENOMICS$0
U54 · FY2001 · GM
INFORMATICS$0
P01 · FY2001 · HG
INSTRUMENTATION$0
P01 · FY2001 · HG
TECHNOLOGY DEVELOPMENT$0
P01 · FY2001 · HG
SEQUENCE OF THE YEAST GENOME$4,844,753
P01 · FY2000 · HG
CELL REGULATION--BIOCHEMICALLY ISOLATED DNA SEGMENTS$1,605,048
R01 · FY2000 · HG
LARGE SCALE DISCOVERY OF SINGLE NUCLEOTIDE POLYMORPHISMS$1,300,000
R01 · FY2000 · HG
LARGE SCALE HUMAN DNA SEQUENCING WITH POLYMORPHISM DISC$1,017,213
U54 · FY2000 · HG
TECHNOLOGY COLLABORATION$939,389
P01 · FY2000 · HG
INSTRUMENTATION$939,389
P01 · FY2000 · HG
TECHNOLOGY DEVELOPMENT$939,389
P01 · FY2000 · HG
AN AIDS-RELATED CRYPTOCOCCUS NEOFORMANS GENOME CENTER$614,870
U01 · FY2000 · AI